The association between cardiovascular disease and breast and gynecologic cancers among black female patients.
暂无分享,去创建一个
V. Sheppard | P. Juarez | M. Mumma | D. Hood | Wansoo Im | C. Lin | Arnethea L. Sutton | K. Williams | D. Addison | Michael T. Mumma | A. Felix
[1] A. Jemal,et al. Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics , 2021, Journal of the National Cancer Institute.
[2] C. Ayers,et al. Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in a Community-Based Cohort: Data From the Washington, D.C. Cardiovascular Health and Needs Assessment , 2021, Frontiers in Cardiovascular Medicine.
[3] N. Magné,et al. Cardiovascular disease events within 5 years after a diagnosis of breast cancer , 2020, BMC Cancer.
[4] L. Collin,et al. A balancing act: racial disparities in cardiovascular disease mortality among women diagnosed with breast cancer. , 2020, Annals of cancer epidemiology.
[5] L. Collin,et al. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer. , 2019, International journal of epidemiology.
[6] K. Bhaskaran,et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases , 2019, The Lancet.
[7] Melonie P. Heron. Deaths: Leading Causes for 2017. , 2019, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[8] D. Hood,et al. Stress, Resilience, and Cardiovascular Disease Risk Among Black Women: Results From the Women’s Health Initiative , 2019, Circulation. Cardiovascular quality and outcomes.
[9] A. Deal,et al. Changes in cardiovascular disease risk and risk factors among women with and without breast cancer , 2018, Cancer.
[10] M. Rutter,et al. The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study , 2018, Gynecologic oncology.
[11] Ken R. Smith,et al. Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. , 2017, Gynecologic oncology.
[12] S. Raman,et al. Cardiovascular disease mortality among women with endometrial cancer in the Iowa Women’s Health Study , 2017, Cancer Causes & Control.
[13] H. Verkooijen,et al. Risk of death from cardiovascular disease following breast cancer: a systematic review , 2017, Breast Cancer Research and Treatment.
[14] F. Harrell,et al. Heart Failure Incidence and Mortality in the Southern Community Cohort Study , 2017, Circulation. Heart failure.
[15] Ahmed Tawakol,et al. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study , 2017, The Lancet.
[16] M. Sherman,et al. High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database , 2016, International journal of cancer.
[17] P. Douglas,et al. Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] A. Blaes,et al. Shared Risk Factors in Cardiovascular Disease and Cancer , 2016, Circulation.
[19] A. Neugut,et al. Cardiovascular Disease Mortality Among Breast Cancer Survivors , 2016, Epidemiology.
[20] C. Ford,et al. The public health critical race methodology: praxis for antiracism research. , 2010, Social science & medicine.
[21] V. Cornelius,et al. Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials , 2010, BMC Cancer.
[22] L. Signorello,et al. The Southern Community Cohort Study: Investigating Health Disparities , 2010, Journal of health care for the poor and underserved.
[23] D. Nerenz,et al. Comorbidity and survival disparities among black and white patients with breast cancer. , 2005, JAMA.